Patents by Inventor Andreas Blum

Andreas Blum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190286682
    Abstract: A system for generating keyword-IeveI landing pages for paid search campaigns associated with website content on a website, the system comprising: a keyword list management module adapted to: receive a set of campaign defined terms, wherein the set of campaign defined terms comprises a plurality of phrases that are actively targeted as SEM keywords in an SEM campaign; a website content gathering module adapted to: receive website content data associated with the website content; a landing page generating module adapted to: retrieve the website content data from the website content gathering module, generate a plurality of landing pages based on the received campaign defined terms and the retrieved website content data; and communicate with a publicly visible web page server to enable the publicly visible web page server to store and serve the generated landing pages.
    Type: Application
    Filed: May 12, 2017
    Publication date: September 19, 2019
    Inventors: Andreas DZUMLA, Will SANTOW, Pragya BAJRACHARYA, Alexia BLUM
  • Patent number: 10336729
    Abstract: The invention relates to new benzonitrile derivatives of the formula (I) wherein R1 to R3 and A are as defined in the description and Claims, to their medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: July 2, 2019
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Frank Himmelsbach, Andreas Blum, Stefan Peters
  • Patent number: 10341462
    Abstract: Providing software-as-a-service to a plurality of clients includes: selecting a first virtual portal, determining a score for a first resource to generate a first scored resource, determining a set of scored resources, visually rendering the first virtual portal and the set of portal resources, visually rendering the set of scored resources, and selecting a scored resource from the set of scored resources to be associated with the first virtual portal by updating the resource association matrix with an identifier of the scored resource. The score is selected to represent a usefulness factor of the first resource. Each scored resource of the set of scored resources is selected to be different than each portal resource of a set of portal resources associated with the first virtual portal by a resource association matrix.
    Type: Grant
    Filed: March 8, 2016
    Date of Patent: July 2, 2019
    Assignee: International Business Machines Corporation
    Inventors: Daniel Blum, Timo Kussmaul, Stefan Schmitt, Andreas Stay
  • Publication number: 20190157924
    Abstract: An electrical synchronous machine is provided for a rail-free vehicle. The vehicle has drive wheels and the synchronous machine is designed to generate a torque, which propels the vehicle, at the drive wheels. The synchronous machine has a stator and a rotor which rotates around the stator, wherein the stator has a stator winding of at least three-phase construction for forming a rotating stator magnetic field, and wherein the rotor has at least one rotor winding which is designed for forming a rotor magnetic field. A method for at least partially circumferentially establishing a current-excited synchronous machine provides a rotor yoke, provides a large number of rotor poles, fastens the rotor poles to the rotor yoke for forming a rotor, provides a stator, and inserts the stator into the rotor.
    Type: Application
    Filed: January 18, 2019
    Publication date: May 23, 2019
    Inventors: Burghard BAIER, Julian BLUM, Dragoljub DURICIC, Zakaria EL KHAWLY, Augusto GUCCIONE, Andreas HUBER, Daniel LOOS, Joerg MERWERTH, Jerome RAGOT, Jan-Oliver ROTH, Berthold SCHINNERL, Jan SOUSEK, Sherif ZAIDAN
  • Publication number: 20190084959
    Abstract: The invention relates to new heteroaryl derivatives of the formula wherein X is selected from the group consisting of: N and CH; X is selected from the group consisting of: N and CF; (whith the proviso that at least one of X1 and X2 is N), and A is as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Application
    Filed: March 3, 2016
    Publication date: March 21, 2019
    Inventors: Frank HIMMELSBACH, Andreas BLUM, Stefan PETERS
  • Publication number: 20190077790
    Abstract: The invention relates to new benzonitrile derivatives of the formula (I) wherein R1 to R3 and A are as defined in the description and Claims, to their medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Application
    Filed: April 3, 2016
    Publication date: March 14, 2019
    Inventors: Frank HIMMELSBACH, Andreas BLUM, Stefan PETERS
  • Patent number: 10167296
    Abstract: The application relates to novel sulfoximine substituted quinazoline derivatives of formula wherein Ar, R1, R2 and R3 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: January 1, 2019
    Assignee: EVOTEC INTERNATIONAL GMBH
    Inventor: Andreas Blum
  • Patent number: 10093660
    Abstract: This invention relates to novel sulfoximine substituted quinazoline derivatives of formula (I), wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
    Type: Grant
    Filed: November 28, 2014
    Date of Patent: October 9, 2018
    Assignee: EVOTEC INTERNATONAL GMBH
    Inventors: Joerg Kley, Andreas Blum, Dirk Gottschling, Joerg P. Hehn, Dieter Wiedenmayer
  • Patent number: 9926292
    Abstract: The invention relates to new pyridinyl derivatives of the formula wherein R1 and A are as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: March 27, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Andreas Blum, Cédrickx Godbout, Joerg P. Hehn, Stefan Peters
  • Publication number: 20170327483
    Abstract: The invention relates to new pyridinyl derivatives of the formula wherein R1 and A are as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Application
    Filed: May 8, 2017
    Publication date: November 16, 2017
    Inventors: Andreas BLUM, Cédrickx GODBOUT, Joerg P. HEHN, Stefan PETERS
  • Publication number: 20170260195
    Abstract: The application relates to novel sulfoximine substituted quinazoline derivatives of formula (I) wherein Ar, R1, R2 and R3 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
    Type: Application
    Filed: April 30, 2015
    Publication date: September 14, 2017
    Inventor: Andreas BLUM
  • Patent number: 9708274
    Abstract: This invention relates to novel sulfoximine substituted quinazoline derivatives of formula I wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: July 18, 2017
    Assignee: EVOTEC INTERNATIONAL GMBH
    Inventors: Andreas Blum, Dirk Gottschling, Armin Heckel, Joerg P. Hehn, Bernhard Schmid, Dieter Wiedenmayer
  • Publication number: 20170174668
    Abstract: This invention relates to novel sulfoximine substituted quinazoline derivatives of formula (I), wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
    Type: Application
    Filed: November 28, 2014
    Publication date: June 22, 2017
    Inventors: Joerg Kley, Andreas Blum, Dirk Gottschling, Joerg P. Hehn, Dieter Wiedenmayer
  • Patent number: 9469631
    Abstract: The present invention relates to compounds of general formula (I), wherein R1, LP, LQ, (Het)Ar, m and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR1 19 receptor and modulate its activity.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: October 18, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Bernd Nosse, Andreas Blum, Armin Heckel, Frank Himmelsbach, Neil J. Ashweek, Nicole Harriott
  • Patent number: 9422312
    Abstract: The present invention relates to compounds of general formula I, wherein the group R1, R2, X, Y and Z are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the AMP-activated protein kinase (AMPK) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: August 23, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Elke Langkopf, Andreas Blum
  • Patent number: 9408319
    Abstract: An electronic component having a molded component housing and an electrically conductive insert part embedded in the component housing for contacting a micro component, the insert part having an accommodating area for accommodating the micro component with a subarea, which is spaced apart from the micro component, for decoupling the micro component from material stresses of the component housing. A method for manufacturing an electronic component having a molded component housing, an electrically conductive insert part for contacting a micro component being embedded in the component housing, a subarea, which is spaced apart from the micro component, decoupling the micro component from material stresses of the component housing, during curing of the housing material, in an accommodating area for accommodating the micro component on the insert part.
    Type: Grant
    Filed: December 2, 2013
    Date of Patent: August 2, 2016
    Assignee: ROBERT BOSCH GMBH
    Inventors: Eberhard Haiss, Martin Rojahn, Matthias Taglieber, Thomas Schrimpf, Matthias Ludwig, Andreas Blum
  • Publication number: 20160039846
    Abstract: The present invention relates to compounds of general formula I, wherein the group R1, R2, X, Y and Z are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the AMP-activated protein kinase (AMPK) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
    Type: Application
    Filed: August 10, 2015
    Publication date: February 11, 2016
    Inventors: Elke LANGKOPF, Andreas BLUM
  • Publication number: 20150361055
    Abstract: This invention relates to novel sulfoximine substituted quinazoline derivatives of formula I wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
    Type: Application
    Filed: July 17, 2015
    Publication date: December 17, 2015
    Inventors: Andreas BLUM, Dirk GOTTSCHLING, Armin HECKEL, Joerg P. HEHN, Bernhard SCHMID, Dieter WIEDENMAYER
  • Patent number: 9139577
    Abstract: This invention relates to novel sulfoximine substituted quinazoline derivatives of formula I wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
    Type: Grant
    Filed: June 26, 2014
    Date of Patent: September 22, 2015
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Andreas Blum, Dirk Gottschling, Armin Heckel, Joerg P. Hehn, Bernhard Schmid, Dieter Wiedenmayer
  • Patent number: 9120258
    Abstract: The invention relates to a device (10; 10a) for encapsulating a component (1) with plastic material (2), comprising at least two tool parts (11, 12), which in a closed arrangement for encapsulating the component (1) form a receptacle (15) for the component (1), an injection channel (30) for supplying the liquefied plastic material (2) to the region of the receptacle (15), and a single retaining element (22) for positioning the component (1) in the receptacle (15), wherein the retaining element (22) can be moved in a first position for positioning the component (1) in the receptacle (15) and in a second position for preferably completely encapsulating the component (1) with the plastic material (2). According to the invention, the retaining element (22) holds the component (1) in the region of the receptacle (15) by means of form positive and/or clamping engagement.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: September 1, 2015
    Assignee: Robert Bosch GmbH
    Inventors: Peter Kunert, Christian Ohl, Matthias Waibler, Matthias Ludwig, Andreas Blum